{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T04:35:28Z","timestamp":1678941328155},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00059-022-05159-x","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T09:03:14Z","timestamp":1674637394000},"page":"95-100","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Akute Herzinsuffizienz und kardiogener Schock"],"prefix":"10.1007","volume":"48","author":[{"given":"Julian G.","family":"Westphal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul Christian","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"issue":"36","key":"5159_CR1","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh\u00a0TA, Metra\u00a0M, Adamo\u00a0M et\u00a0al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart\u00a0J 42(36):3599\u20133726","journal-title":"Eur Heart J"},{"issue":"2","key":"5159_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.tcm.2019.03.007","volume":"30","author":"L Sinnenberg","year":"2020","unstructured":"Sinnenberg\u00a0L, Givertz\u00a0MM (2020) Acute heart failure. Trends Cardiovasc Med 30(2):104\u2013112","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"5159_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11897-017-0351-y","volume":"14","author":"S Kurmani","year":"2017","unstructured":"Kurmani\u00a0S, Squire\u00a0I (2017) Acute heart failure: definition, classification and epidemiology. Curr Heart Fail Rep 14(5):385\u2013392","journal-title":"Curr Heart Fail Rep"},{"issue":"22","key":"5159_CR4","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/eurheartj\/ehl193","volume":"27","author":"MS Nieminen","year":"2006","unstructured":"Nieminen\u00a0MS, Brutsaert\u00a0D, Dickstein\u00a0K et\u00a0al (2006) EuroHeart Failure Survey II (EHFS II): a\u00a0survey on hospitalized acute heart failure patients: description of population. Eur Heart\u00a0J 27(22):2725\u20132736","journal-title":"Eur Heart J"},{"issue":"10","key":"5159_CR5","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/S0735-1097(03)00309-7","volume":"41","author":"A Nohria","year":"2003","unstructured":"Nohria\u00a0A, Tsang\u00a0SW, Fang\u00a0JC et\u00a0al (2003) Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J\u00a0Am Coll Cardiol 41(10):1797\u20131804","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"5159_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/ejhf.901","volume":"20","author":"E Platz","year":"2018","unstructured":"Platz\u00a0E, Jhund\u00a0PS, Claggett\u00a0BL et\u00a0al (2018) Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality. Eur J Heart Fail 20(2):295\u2013303","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"5159_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ejhf.1369","volume":"21","author":"W Mullens","year":"2019","unstructured":"Mullens\u00a0W, Damman\u00a0K, Harjola\u00a0VP et\u00a0al (2019) The use of diuretics in heart failure with congestion\u2014A\u00a0position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21(2):137\u2013155","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"5159_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/CRD.0000000000000310","volume":"29","author":"R Rahman","year":"2021","unstructured":"Rahman\u00a0R, Paz\u00a0P, Elmassry\u00a0M et\u00a0al (2021) Diuretic resistance in heart failure. Cardiol Rev 29(2):73\u201381","journal-title":"Cardiol Rev"},{"issue":"19","key":"5159_CR9","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1001\/jama.2020.19378","volume":"324","author":"Y Freund","year":"2020","unstructured":"Freund\u00a0Y, Cachanado\u00a0M, Delannoy\u00a0Q et al (2020) Effect of an emergency department care bundle on 30-day hospital discharge and survival among elderly patients with acute heart failure: the ELISABETH randomized clinical trial. JAMA 324(19):1948\u20131956","journal-title":"JAMA"},{"issue":"23","key":"5159_CR10","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1001\/jama.2019.18598","volume":"322","author":"N Kozhuharov","year":"2019","unstructured":"Kozhuharov\u00a0N, Goudev\u00a0A, Flores\u00a0D et\u00a0al (2019) Effect of a\u00a0strategy of comprehensive vasodilation vs usual care on mortality and heart failure rehospitalization among patients with acute heart failure: the GALACTIC randomized clinical trial. JAMA 322(23):2292\u20132302","journal-title":"JAMA"},{"issue":"3","key":"5159_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.15420\/cfr.2019.11.2","volume":"5","author":"V Bistola","year":"2019","unstructured":"Bistola\u00a0V, Arfaras-Melainis\u00a0A, Polyzogopoulou\u00a0E et al (2019) Inotropes in acute heart failure: From guidelines to practical use: therapeutic options and clinical practice. Card Fail Rev 5(3):133\u2013139","journal-title":"Card Fail Rev"},{"issue":"10","key":"5159_CR12","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.107.728840","volume":"118","author":"CB Overgaard","year":"2008","unstructured":"Overgaard\u00a0CB, Dzavik\u00a0V (2008) Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease. Circulation 118(10):1047\u20131056","journal-title":"Circulation"},{"key":"5159_CR13","doi-asserted-by":"publisher","first-page":"696138","DOI":"10.3389\/fcvm.2021.696138","volume":"8","author":"F Gao","year":"2021","unstructured":"Gao\u00a0F, Zhang\u00a0Y (2021) Inotrope use and intensive care unit mortality in patients with cardiogenic shock: an analysis of a\u00a0large electronic intensive care unit database. Front Cardiovasc Med 8:696138","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"5159_CR14","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","volume":"287","author":"MS Cuffe","year":"2002","unstructured":"Cuffe\u00a0MS, Califf\u00a0RM, Adams\u00a0KF et al (2002) Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a\u00a0randomized controlled trial. JAMA 287(12):1541\u20131547","journal-title":"JAMA"},{"issue":"2","key":"5159_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jchf.2012.12.004","volume":"1","author":"M Packer","year":"2013","unstructured":"Packer\u00a0M, Colucci\u00a0W, Fisher\u00a0L et al (2013) Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. JACC Heart Fail 1(2):103\u2013111","journal-title":"JACC Heart Fail"},{"issue":"17","key":"5159_CR16","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","volume":"297","author":"A Mebazaa","year":"2007","unstructured":"Mebazaa\u00a0A, Nieminen\u00a0MS, Packer\u00a0M et\u00a0al (2007) Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 297(17):1883\u20131891","journal-title":"JAMA"},{"issue":"3\u20134","key":"5159_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000047397","volume":"96","author":"DH Ellison","year":"2001","unstructured":"Ellison\u00a0DH (2001) Diuretic therapy and resistance in congestive heart failure. Cardiology 96(3\u20134):132\u2013143","journal-title":"Cardiology"},{"issue":"3","key":"5159_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.amjcard.2015.10.059","volume":"117","author":"RJ Mentz","year":"2016","unstructured":"Mentz\u00a0RJ, Hasselblad\u00a0V, DeVore\u00a0AD et al (2016) Torsemide versus furosemide in patients with acute heart failure (from the ASCEND-HF trial). Am J Cardiol 117(3):404\u2013411","journal-title":"Am J Cardiol"},{"issue":"5","key":"5159_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2217\/fca.15.56","volume":"11","author":"RJ Mentz","year":"2015","unstructured":"Mentz\u00a0RJ, Velazquez\u00a0EJ, Metra\u00a0M et\u00a0al (2015) Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial. Future Cardiol 11(5):585\u2013595","journal-title":"Future Cardiol"},{"issue":"23","key":"5159_CR20","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1001\/jama.2013.282190","volume":"310","author":"HH Chen","year":"2013","unstructured":"Chen\u00a0HH, Anstrom\u00a0KJ, Givertz\u00a0MM et al (2013) Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA 310(23):2533\u20132543","journal-title":"JAMA"},{"issue":"13","key":"5159_CR21","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.jacc.2013.04.073","volume":"62","author":"SS Gottlieb","year":"2013","unstructured":"Gottlieb\u00a0SS, Stebbins\u00a0A, Voors\u00a0AA et al (2013) Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure). J\u00a0Am Coll Cardiol 62(13):1177\u20131183","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"5159_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1136\/hrt.71.2.146","volume":"71","author":"KS Channer","year":"1994","unstructured":"Channer\u00a0KS, McLean\u00a0KA, Lawson-Matthew\u00a0P, Richardson\u00a0M (1994) Combination diuretic treatment in severe heart failure: a\u00a0randomised controlled trial. Br Heart\u00a0J 71(2):146\u2013150","journal-title":"Br Heart J"},{"issue":"13","key":"5159_CR23","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","volume":"387","author":"W Mullens","year":"2022","unstructured":"Mullens\u00a0W, Dauw\u00a0J, Martens\u00a0P et\u00a0al (2022) Acetazolamide in acute decompensated heart failure with volume overload. N\u00a0Engl J Med 387(13):1185\u20131195","journal-title":"N Engl J Med"},{"issue":"4","key":"5159_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.122.059038","volume":"146","author":"PC Schulze","year":"2022","unstructured":"Schulze\u00a0PC, Bogoviku\u00a0J, Westphal\u00a0J et al (2022) Effects of early empagliflozin initiation on diuresis and kidney function in patients with acute decompensated heart failure (EMPAG-HF). Circulation 146(4):289\u2013298","journal-title":"Circulation"},{"issue":"3","key":"5159_CR25","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","volume":"28","author":"AA Voors","year":"2022","unstructured":"Voors\u00a0AA, Angermann\u00a0CE, Teerlink\u00a0JR et\u00a0al (2022) The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: A\u00a0multinational randomized trial. Nat Med 28(3):568\u2013574","journal-title":"Nat Med"},{"issue":"4","key":"5159_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrcardio.2015.14","volume":"12","author":"SJ Greene","year":"2015","unstructured":"Greene\u00a0SJ, Fonarow\u00a0GC, Vaduganathan\u00a0M et\u00a0al (2015) The vulnerable phase after hospitalization for heart failure. Nat Rev Cardiol 12(4):220\u2013229","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"5159_CR27","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jchf.2020.05.013","volume":"8","author":"SJ Greene","year":"2020","unstructured":"Greene\u00a0SJ, Triana\u00a0TS, Ionescu-Ittu\u00a0R et al (2020) In-hospital therapy for heart failure with reduced ejection fraction in the United States. JACC Heart Fail 8(11):943\u2013953","journal-title":"JACC Heart Fail"},{"issue":"16","key":"5159_CR28","doi-asserted-by":"publisher","first-page":"e015042","DOI":"10.1161\/JAHA.119.015042","volume":"9","author":"HS Wirtz","year":"2020","unstructured":"Wirtz\u00a0HS, Sheer\u00a0R, Honarpour\u00a0N et al (2020) Real-world analysis of guideline-based therapy after hospitalization for heart failure. J\u00a0Am Heart Assoc 9(16):e15042","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"5159_CR29","doi-asserted-by":"publisher","first-page":"e001462","DOI":"10.1161\/JAHA.114.001462","volume":"4","author":"S Shaefi","year":"2015","unstructured":"Shaefi\u00a0S, O\u2019Gara\u00a0B, Kociol\u00a0RD et\u00a0al (2015) Effect of cardiogenic shock hospital volume on mortality in patients with cardiogenic shock. J\u00a0Am Heart Assoc 4(1):e1462","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"5159_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJM199908263410901","volume":"341","author":"JS Hochman","year":"1999","unstructured":"Hochman\u00a0JS, Sleeper\u00a0LA, Webb\u00a0JG et\u00a0al (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N\u00a0Engl J Med 341(9):625\u2013634","journal-title":"N Engl J Med"},{"issue":"9","key":"5159_CR31","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1161\/CIRCULATIONAHA.108.814947","volume":"119","author":"RJ Goldberg","year":"2009","unstructured":"Goldberg\u00a0RJ, Spencer\u00a0FA, Gore\u00a0JM et al (2009) Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a\u00a0population-based perspective. Circulation 119(9):1211\u20131219","journal-title":"Circulation"},{"issue":"5","key":"5159_CR32","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s13054-014-0516-y","volume":"18","author":"N Aissaoui","year":"2014","unstructured":"Aissaoui\u00a0N, Puymirat\u00a0E, Simon\u00a0T et al (2014) Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a\u00a0landmark analysis from the French registry of Acute ST-elevation and non-ST-elevation myocardial Infarction (FAST-MI) registry. Crit Care 18(5):516","journal-title":"Crit Care"},{"issue":"10245","key":"5159_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0140-6736(20)31047-3","volume":"396","author":"A Combes","year":"2020","unstructured":"Combes\u00a0A, Price\u00a0S, Slutsky\u00a0AS, Brodie\u00a0D (2020) Temporary circulatory support for cardiogenic shock. Lancet 396(10245):199\u2013212","journal-title":"Lancet"},{"key":"5159_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.carrev.2021.01.028","volume":"34","author":"A Moustafa","year":"2022","unstructured":"Moustafa\u00a0A, Khan\u00a0MS, Saad\u00a0M et al (2022) Impella support versus intra-aortic balloon pump in acute myocardial infarction complicated by cardiogenic shock: a meta-analysis. Cardiovasc Revasc Med 34:25\u201331","journal-title":"Cardiovasc Revasc Med"},{"issue":"14","key":"5159_CR35","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","volume":"367","author":"H Thiele","year":"2012","unstructured":"Thiele\u00a0H, Zeymer\u00a0U, Neumann\u00a0FJ et\u00a0al (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N\u00a0Engl J Med 367(14):1287\u20131296","journal-title":"N Engl J Med"},{"key":"5159_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ahj.2019.04.019","volume":"214","author":"NJ Udesen","year":"2019","unstructured":"Udesen\u00a0NJ, Moller\u00a0JE, Lindholm\u00a0MG et al (2019) Rationale and design of DanGer shock: Danish-German cardiogenic shock trial. Am Heart\u00a0J 214:60\u201368","journal-title":"Am Heart J"},{"key":"5159_CR37","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.122.062949","author":"P Ostadal","year":"2022","unstructured":"Ostadal\u00a0P, Rokyta\u00a0R, Karasek\u00a0J et al (2022) Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: Results of the ECMO-CS randomized clinical trial. Circulation. https:\/\/doi.org\/10.1161\/circulationaha.122.062949","journal-title":"Circulation"},{"key":"5159_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2021.01.002","volume":"234","author":"H Thiele","year":"2021","unstructured":"Thiele\u00a0H, Freund\u00a0A, Gimenez\u00a0MR et al (2021) Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock\u2014Design and rationale of the ECLS-SHOCK trial. Am Heart\u00a0J 234:1\u201311","journal-title":"Am Heart J"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-022-05159-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-022-05159-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-022-05159-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T16:03:03Z","timestamp":1678896183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-022-05159-x"}},"subtitle":["Ein Update"],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["5159"],"URL":"https:\/\/doi.org\/10.1007\/s00059-022-05159-x","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"19 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.G.\u00a0Westphal und P.C.\u00a0Schulze geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}